IXIFI Trademark

Trademark Overview

On Tuesday, September 20, 2016, a trademark application was filed for IXIFI with the United States Patent and Trademark Office. The USPTO has given the IXIFI trademark a serial number of 87176648. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Tuesday, April 7, 2020. This trademark is owned by Pfizer Inc.. The IXIFI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, smoking cessation preparations, tissue repair preparations, and preparations for use in dermatology and oncology; vaccines for human use
ixifi

General Information

Serial Number87176648
Word MarkIXIFI
Filing DateTuesday, September 20, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateTuesday, April 7, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 7, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, smoking cessation preparations, tissue repair preparations, and preparations for use in dermatology and oncology; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 23, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, June 8, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Friday, June 5, 2020ABANDONMENT - NO USE STATEMENT FILED
Thursday, October 10, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 9, 2019EXTENSION 5 GRANTED
Friday, October 4, 2019EXTENSION 5 FILED
Wednesday, October 9, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, October 4, 2019TEAS EXTENSION RECEIVED
Thursday, October 3, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 3, 2019ASSIGNED TO LIE
Tuesday, October 1, 2019TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, April 2, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 29, 2019EXTENSION 4 GRANTED
Friday, March 29, 2019EXTENSION 4 FILED
Friday, March 29, 2019TEAS EXTENSION RECEIVED
Friday, September 28, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 26, 2018EXTENSION 3 GRANTED
Wednesday, September 26, 2018EXTENSION 3 FILED
Wednesday, September 26, 2018TEAS EXTENSION RECEIVED
Thursday, March 22, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 20, 2018EXTENSION 2 GRANTED
Tuesday, March 20, 2018EXTENSION 2 FILED
Tuesday, March 20, 2018TEAS EXTENSION RECEIVED
Wednesday, September 27, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 25, 2017EXTENSION 1 GRANTED
Monday, September 25, 2017EXTENSION 1 FILED
Monday, September 25, 2017TEAS EXTENSION RECEIVED
Tuesday, April 4, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 7, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 7, 2017PUBLISHED FOR OPPOSITION
Wednesday, January 18, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 29, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 27, 2016ASSIGNED TO EXAMINER
Friday, September 23, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, September 23, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

ixifi preparations pharmaceutical dysfunction treatment cancer diabetes sexual pain disorders diseases